Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.03. | DYNAVAX TECHNOLOGIES CORP - 8-K, Current Report | 3 | SEC Filings | ||
23.02. | Earnings call: Dynavax reports record revenue growth in 2023 | 14 | Investing.com | ||
22.02. | DYNAVAX TECHNOLOGIES CORP - 10-K, Annual Report | 6 | SEC Filings | ||
22.02. | Dynavax Technologies: Q4 Earnings Insights | 10 | Benzinga.com | ||
22.02. | DYNAVAX TECHNOLOGIES CORP - 8-K, Current Report | 3 | SEC Filings | ||
22.02. | Dynavax Technologies: Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance | 538 | PR Newswire | HEPLISAV-B® 2023 net product revenue grew 69% year-over-year to $213 million
Achieved market leader status in key segments retail pharmacy and IDNs in 2023
2024 HEPLISAV-B net product revenue expected... ► Artikel lesen | |
08.01. | Dynavax reports 46% Y/Y increase in HEPLISAV-B vaccine net product revenue | 24 | Seeking Alpha | ||
08.01. | DYNAVAX TECHNOLOGIES CORP - 8-K, Current Report | 6 | SEC Filings | ||
08.01. | Dynavax Technologies: Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights | 333 | PR Newswire | Preliminary full year 2023 HEPLISAV-B® vaccine net product revenue of approximately $213 million, a 69% year-over-year increase
Significant gains in HEPLISAV-B market share in key market segments... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 606 |
BAYER | 400 |
BYD | 335 |
NEL | 320 |
NVIDIA | 292 |
TESLA | 282 |
DEUTSCHE BANK | 276 |
TUI | 275 |
PLUG POWER | 272 |
SUPER MICRO COMPUTER | 253 |
APPLE | 239 |
RHEINMETALL | 234 |
RWE | 225 |
MERCEDES-BENZ | 211 |
DEUTSCHE LUFTHANSA | 206 |
AMAZON | 194 |
BERKSHIRE HATHAWAY | 192 |
RENK GROUP | 162 |
VOLKSWAGEN | 160 |
ALLIANZ | 158 |
BIONTECH | 154 |
COMMERZBANK | 154 |
AIXTRON SE | 153 |
PAYPAL | 151 |
BASF | 149 |